The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell(S) | 5K | $80.30 | $369K |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Grant(A) | 37K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Grant(A) | 9K | — | $0 |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Tax withholding(F) | 4K | $79.28 | $318K |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Moat Ross | CHIEF OPERATING OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Grant(A) | 27K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Grant(A) | 7K | — | $0 |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Tax withholding(F) | 4K | $79.28 | $319K |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Paolini John F. | CHIEF MEDICAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 4K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Grant(A) | 15K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Grant(A) | 4K | — | $0 |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Tax withholding(F) | 6K | $79.28 | $438K |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 3K | — | — |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 3K | — | — |
| Sep 1, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 4K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 10K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 9K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Grant(A) | 120K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Grant(A) | 30K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Tax withholding(F) | 15K | $79.28 | $1.2M |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 9K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 10K | — | — |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Grant(A) | 31K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Grant(A) | 8K | — | $0 |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 4K | $79.28 | $349K |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 10K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 9K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Grant(A) | 120K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Grant(A) | 30K | — | $0 |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Tax withholding(F) | 15K | $79.28 | $1.2M |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 9K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 6K | — | — |
| Sep 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Option exercise(M) | 10K | — | — |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | — | — |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | — |
| Sep 1, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | — | — |
| Aug 19, 2026 | Quart Barry D | Director | Gift(G) | 3K | — | $0 |
| Aug 1, 2026 | Levy Richard S | Director | Option exercise(M) | 403 | — | — |
| Aug 1, 2026 | Levy Richard S | Director | Grant(A) | 403 | — | $0 |
| Aug 1, 2026 | Levy Richard S | Director | Option exercise(M) | 403 | — | $0 |
| Jul 29, 2026 | Cole G Bradley | Director | Sell(S) | 4K | $81.43 | $299K |
| Jul 29, 2026 | Cole G Bradley | Director | Gift(G) | 5K | — | $0 |
| Jul 15, 2026 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Grant(A) | 279 | $33.50 | $9K |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 83K | — | $0 |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 14K | — | $0 |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 2K | — | $0 |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 2K | — | $0 |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 1K | — | $0 |
| Jul 1, 2026 | Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Grant(A) | 1K | — | $0 |
| Jun 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Conversion(C) | 900K | — | — |
| Jun 1, 2026 | Patel Sanj K | CHAIRMAN & CEO, Director | Conversion(C) | 900K | — | $0 |
| May 29, 2026 | Cole G Bradley | Director | Option exercise(M) | 3K | — | — |
| May 29, 2026 | Cole G Bradley | Director | Grant(A) | 12K | — | $0 |
| May 29, 2026 | Cole G Bradley | Director | Grant(A) | 2K | — | $0 |
| May 29, 2026 | Cole G Bradley | Director | Option exercise(M) | 3K | — | $0 |
| May 29, 2026 | Baker Bros. Advisors LP | Director | Grant(A) | 6K | — | $0 |
| May 29, 2026 | Baker Bros. Advisors LP | Director | Grant(A) | 6K | — | $0 |
| May 29, 2026 | Baker Bros. Advisors LP | Director | Grant(A) | 36K | — | $0 |
| May 29, 2026 | Baker Bros. Advisors LP | Director | Grant(A) | 36K | — | $0 |
| May 29, 2026 | Popovits Kimberly J | Director | Option exercise(M) | 3K | — | — |
| May 29, 2026 | Popovits Kimberly J | Director | Grant(A) | 12K | — | $0 |
| May 29, 2026 | Popovits Kimberly J | Director | Grant(A) | 2K | — | $0 |
| May 29, 2026 | Popovits Kimberly J | Director | Option exercise(M) | 3K | — | $0 |
| May 29, 2026 | Quart Barry D | Director | Option exercise(M) | 3K | — | — |
| May 29, 2026 | Quart Barry D | Director | Grant(A) | 12K | — | $0 |
| May 29, 2026 | Quart Barry D | Director | Grant(A) | 2K | — | $0 |
| May 29, 2026 | Quart Barry D | Director | Option exercise(M) | 3K | — | $0 |
| May 29, 2026 | Malley Thomas | Director | Option exercise(M) | 3K | — | — |
| May 29, 2026 | Malley Thomas | Director | Grant(A) | 12K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Kiniksa Pharmaceuticals International, plc, SEC CIK 0001730430. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under KNSA and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for KNSA